China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
株式のランク
#2914
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent... China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent pharmaceutical enterprise engaged in the research, development, manufacturing, and distribution of medicinal products. Its operations span both the People's Republic of China and international markets, additionally providing various health-related services. The company's extensive product line includes a wide range of over-the-counter (OTC) medications addressing common conditions such as colds, skin issues, gastrointestinal complaints, coughs, and needs in orthopedics and pediatrics. It also provides prescription drugs, with a focus on areas like traditional Chinese medicine, oncology, cardiovascular and cerebrovascular health, digestive system disorders, orthopedics, and pediatrics. Further offerings comprise Chinese medicine injections, specialized formula granules, and anti-infective agents. These products are often marketed under popular brand families, notably 999 family medicine, Sanjiuweitai series, 999 Ganmaoling series, and 999 dermatitis series. Founded in 1999 and headquartered in Shenzhen, PRC, the company initially operated as Sanjiu Pharmaceutical Co., Ltd. before rebranding to its current name in February 2010. It functions as a subsidiary under the umbrella of China Resources (Holdings) Co., Ltd.
株価
$3.74
時価総額
$6.23B
変化（1日）
-2.11%
変化（1年）
-8.54%
国
CN
取引 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999)
カテゴリー
Healthcare
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.（000999）の配当利回りの履歴
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.（銘柄コード: 000999）の配当利回り（TTM）は2024-12-31時点で4.99%です。
過去5年間の平均配当利回り: 2.60%
過去5年間の平均配当利回り: 2.60%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.（000999）の2001から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
| 年 | 配当利回り | 変化 |
|---|---|---|
| 2026 (TTM) | 4.02% | 51.13% |
| 2025 | 2.66% | -46.69% |
| 2024 | 4.99% | 142.23% |
| 2023 | 2.06% | 13.19% |
| 2022 | 1.82% | 22.97% |
| 2021 | 1.48% | -13.95% |
| 2020 | 1.72% | 39.84% |
| 2019 | 1.23% | -40.00% |
| 2018 | 2.05% | 201.47% |
| 2017 | 0.68% | -2.86% |
| 2016 | 0.70% | -55.97% |
| 2015 | 1.59% | 21.37% |
| 2014 | 1.31% | -17.09% |
| 2013 | 1.58% | -15.05% |
| 2012 | 1.86% | -20.85% |
| 2011 | 2.35% | 53.59% |
| 2010 | 1.53% | 15.04% |
| 2009 | 1.33% | 1,109.09% |
| 2008 | 0.11% | 0.00% |
| 2007 | 0.11% | -95.82% |
| 2006 | 2.63% | -62.21% |
| 2005 | 6.96% | -33.46% |
| 2004 | 10.46% | -24.48% |
| 2003 | 13.85% | 19.19% |
| 2002 | 11.62% | 5.83% |
| 2001 | 10.98% | 0.00% |
類似企業または競合他社の配当利回り（TTM）
| 企業 | 配当利回り | 国 |
|---|---|---|
| 1.63% |
DE
|
|
| 1.50% |
DE
|
|
| 3.18% |
JP
|
|
| 0.19% |
CH
|
|
| 0.91% |
IN
|
